TrialBMC musculoskeletal disorders2017

Reduction of the Serum Levels of a Specific Biomarker of Cartilage Degradation (Coll2-1) by Hyaluronic Acid (KARTILAGE® CROSS) Compared to Placebo in Painful Knee Osteoarthritis Patients: the EPIKART Study, a Pilot Prospective Comparative Randomized Double Blind Trial.

Yves Henrotin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.